Gland Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges that the trading window for dealing in its securities will be closed from Saturday, June 28, 2025, until 48 hours after the company announces its unaudited financial results for the quarter ending June 30, 2025. This is a routine compliance measure required under SEBI's Prohibition of Insider Trading Regulations, 2015, to prevent insider trading ahead of the quarterly results. The date of the board meeting to approve these Q1 FY26 results has not yet been disclosed and will be communicated later.
This is a standard regulatory announcement with no direct impact on the stock price or shareholders. However, it signals that Q1 FY26 results are expected soon, and insiders (directors, employees, etc.) will not be able to trade in the stock during this period. Retail investors should watch for the upcoming board meeting date and earnings announcement, which could be a catalyst for the stock.